• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS DIVISION CELL-DYN RUBY ANALYZER; AUTOMATED HEMATOLOGY ANALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS DIVISION CELL-DYN RUBY ANALYZER; AUTOMATED HEMATOLOGY ANALYZER Back to Search Results
Catalog Number 08H67-01
Device Problem High Test Results (2457)
Patient Problem No Code Available (3191)
Event Date 07/29/2019
Event Type  malfunction  
Manufacturer Narrative
There is no further patient information provided due to privacy issues.An evaluation is in process.A final report will be submitted when the evaluation is complete.
 
Event Description
The customer reported the cell dyn ruby rbc results are not matching the alinity hq analyzer.Rbc results are used to calculate the hematocrit (hct), therefore the hct values are elevated on the cd ruby compared to the alinity hq.The customer performs therapeutic phlebotomies on polycythemia vera patients based on the hct and their decision point is >0.45.The patient results provided: on (b)(6) 2019 (b)(6) ruby =0.467 / alinity = 0.416.This patient had an unnecessary therapeutic phlebotomy based on the elevated ruby hct results.
 
Manufacturer Narrative
A review of product historical data for any trends and all customer complaints received for this issue did not identify any trends or complaints.Return testing was not completed as returns were not available.The red blood cells (rbc) measured significantly higher on the ruby than the alinity, the platelets (plt) measured significantly lower on the ruby than the alinity, and the hemoglobin and the mcv showed good agreement between the analyzers.The difference in the rbc measurement is the contributing factor for the higher hct results reported from the ruby.On 19sep2019, the ruby serial number (sn) (b)(4) analyzer was calibrated to ruby sn (b)(4) to correct rbc, plt and hct bias between this analyzer and all other fbc analyzers in the hospital.On 11oct2019, comparison studies between all hematology analyzers in the hospital found the hct, rbc and plt results to be acceptable.The most likely explanation for the incident is that even though both instruments are calibrated with their own calibrators properly, to compare results, the two instruments need to be cross calibrated according to the method described in clsi h26-a2, the alinity hq operations manual, and the cell-dyn ruby operator's manual.A review of labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the cell-dyn ruby, sn (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELL-DYN RUBY ANALYZER
Type of Device
AUTOMATED HEMATOLOGY ANALYZER
Manufacturer (Section D)
ABBOTT DIAGNOSTICS DIVISION
4551 great america parkway
santa clara CA 95054
MDR Report Key8953789
MDR Text Key184177640
Report Number2919069-2019-00095
Device Sequence Number1
Product Code GKZ
UDI-Device Identifier00380740017170
UDI-Public00380740017170
Combination Product (y/n)N
PMA/PMN Number
K061667
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 10/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/02/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number08H67-01
Was Device Available for Evaluation? No
Date Manufacturer Received10/16/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-